Patent · US Expired

Method for the treatment of malaria by the use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4- (6-methoxy-8-quinolinyl)-1,4-pentanediamine as gametocytocidal agent

US7183291B2 · kind B2 · utility

0Cited by

2References

7Claims

0Family size

Assignee

COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH · IN

Inventors

Ram Pratap · Lucknow, IN
Amiya Prasad Bhaduri · Lucknow, IN
Harsh Pati Thapliyal · Lucknow, IN
Sunil Puri · Burnaby, CA
Guru Prasad Dutta · Lucknow, IN
Anil Kumar Dwivedi · Lucknow, IN
Satyawan Singh · Lucknow, IN
Pratima Srivastava · Lucknow, IN
Vikash Chandra Pandey · Lucknow, IN
Sudhir Srivastava · Eindhoven, NL
Shio Kumar Singh · Lucknow, IN
Ram Gupta · Lucknow, IN
Jagdishwar Sahai Srivastava · Lucknow, IN
Omkar Prasad Asthana · Lucknow, IN

Key dates

Filing date	May 21, 1999
Grant date	Feb 27, 2007
Priority date	—
Expiry date	May 21, 2019

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention a novel use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine in the treatment and controlling the spread of malaria. In particular, the present invention discloses a method of treatment of malaria by the use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine as a gametocytocidal agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.